BlackRock Fund Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1K | Buy |
672
+97
| +17% | +$144 | ﹤0.01% | 4237 |
|
|
2016
Q3 | $3K | Buy |
575
+60
| +12% | +$313 | ﹤0.01% | 4160 |
|
|
2016
Q2 | $5K | Buy |
515
+39
| +8% | +$379 | ﹤0.01% | 4111 |
|
|
2016
Q1 | $6K | Buy |
476
+92
| +24% | +$1.16K | ﹤0.01% | 4079 |
|
|
2015
Q4 | $5K | Buy |
+384
| New | +$5K | ﹤0.01% | 4162 |
|
|
2015
Q2 | – | Sell |
-5,753
| Closed | -$112K | – | 4004 |
|
|
2015
Q1 | $112K | Buy |
5,753
+1,405
| +32% | +$27.4K | ﹤0.01% | 3601 |
|
|
2014
Q4 | $127K | Buy |
4,348
+310
| +8% | +$9.06K | ﹤0.01% | 3582 |
|
|
2014
Q3 | $144K | Sell |
4,038
-293
| -7% | -$10.4K | ﹤0.01% | 3575 |
|
|
2014
Q2 | $194K | Buy |
4,331
+124
| +3% | +$5.55K | ﹤0.01% | 3501 |
|
|
2014
Q1 | $205K | Buy |
4,207
+510
| +14% | +$24.9K | ﹤0.01% | 3458 |
|
|
2013
Q4 | $137K | Buy |
3,697
+155
| +4% | +$5.74K | ﹤0.01% | 3526 |
|
|
2013
Q3 | $364K | Buy |
3,542
+105
| +3% | +$10.8K | ﹤0.01% | 3238 |
|
|
2013
Q2 | $267K | Buy |
+3,437
| New | +$267K | ﹤0.01% | 3239 |
|